Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Replenology is a specialized biotechnology and consumer health company focused on hair follicle health and regrowth. The company utilizes its proprietary Follicle Five technology, which targets five key metabolic pathways essential for healthy hair growth: nutrient support, DHT modulation, inflammation reduction, circulation enhancement, and follicle protection. Their product line includes a comprehensive system of dietary supplements, topical activators, and specialized shampoos designed to address various forms of hair loss, including androgenetic alopecia and telogen effluvium. Replenology's approach is distinguished by its use of clinically studied botanical and nutrient-based ingredients to provide a non-drug alternative for hair restoration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Replenology.